Search

Search Results

• RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study

  F. Perdoni, M. Malatesta, R. Cardani, M. Giagnacovo, E. Mancinelli, G. Meola, C. Pellicciari

  e18

  23-09-2009

  https://doi.org/10.4081/ejh.2009.e18

  1564

  PDF: 850
• 

  Tibialis anterior muscle needle biopsy and sensitive biomolecular methods: a useful tool in myotonic dystrophy type 1

  S. Iachettini, R. Valaperta, A. Marchesi, A. Perfetti, G. Cuomo, B. Fossati, L. Vaienti, E. Costa, G. Meola, R. Cardani

  26-10-2015

  https://doi.org/10.4081/ejh.2015.2562

  1849

  PDF: 871

  HTML: 389
• 

  Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction

  L.V. Renna, R. Cardani, A. Botta, G. Rossi, B. Fossati, E. Costa, G. Meola

  22-10-2014

  https://doi.org/10.4081/ejh.2014.2444

  2284

  PDF: 996

  HTML: 474
• 

  Structural and functional alterations of the cell nucleus in skeletal muscle wasting: the evidence in situ

  M. Malatesta, G. Meola

  e44

  19-10-2010

  https://doi.org/10.4081/ejh.2010.e44

  1415

  PDF: 554

  HTML: 587
• 

  Muscleblind-like1 undergoes ectopic relocation in the nuclei of skeletal muscles in myotonic dystrophy and sarcopenia

  M. Malatesta, M. Giagnacovo, M. Costanzo, B. Cisterna, R. Cardani, G. Meola

  e15

  22-04-2013

  https://doi.org/10.4081/ejh.2013.e15

  2790

  PDF: 4251

  HTML: 460
• 

  Cultured myoblasts from patients affected by myotonic dystrophy type 2 exhibit senescence-related features: ultrastructural evidence

  M. Malatesta, M. Giagnacovo, L.V. Renna, R. Cardani, G. Meola, C. Pellicciari

  e26

  21-09-2011

  https://doi.org/10.4081/ejh.2011.e26

  1932

  PDF: 701
• 

  Routinely frozen biopsies of human skeletal muscle are suitable for morphological and immunocytochemical analyses at transmission electron microscopy

  M. Giagnacovo, R. Cardani, G. Meola, C. Pellicciari, M. Malatesta

  e31

  08-07-2010

  https://doi.org/10.4081/ejh.2010.e31

  1446

  PDF: 736

  HTML: 9352

• Muscle biopsy and cell cultures: potential diagnostic tools in hereditary skeletal muscle channelopathies

  G Meola, V Sansone, G Rotondo, E Mancinelli

  17-28

  26-06-2009

  https://doi.org/10.4081/803

  645

  PDF: 705

• Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies

  R Cardani, E Mancinelli, M Giagnacovo, V Sansone, G Meola

  e13

  17-08-2009

  https://doi.org/10.4081/ejh.2009.e13

  1043

  PDF: 671

• IDMC-6 - The Sixth International Myotonic Dystrophy Consortium Meeting

  G Meola

  311-313

  10-08-2009

  https://doi.org/10.4081/1157

  596

  PDF: 540

• Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2

  R Cardani, E Mancinelli, G Rotondo, V Sansone, G Meola

  177-182

  30-06-2009

  https://doi.org/10.4081/990

  536

  PDF: 341

• Apoptosis induced by proteasome inhibition in human myoblast cultures

  J Sassone, A Ciammola, C Tiloca, M Glionna, G Meola, E Mancinelli, V Silani

  109-118

  30-06-2009

  https://doi.org/10.4081/981

  490

  PDF: 418

• Advanced microscopic and histochemical techniques: diagnostic tools in the molecular era of myology

  G Meola

  93-96

  29-06-2009

  https://doi.org/10.4081/932

  692

  PDF: 661

• Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy

  R Cardani, E Mancinelli, V Sansone, G Rotondo, G Meola

  437-442

  29-06-2009

  https://doi.org/10.4081/918

  954

  PDF: 729